| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/29/2006 | CA2591997A1 Compositions comprising an epothilone and production methods |
| 06/29/2006 | CA2591923A1 Enteric coated azithromycin multiparticulates |
| 06/29/2006 | CA2591806A1 Tablet formulation for sustained drug-release |
| 06/29/2006 | CA2591767A1 Solid lipidic particles as pharmaceutically acceptable fillers or carriers for inhalation |
| 06/29/2006 | CA2591747A1 Orally disintegrating pharmaceutical compositions with sensory cue agents |
| 06/29/2006 | CA2591744A1 Stable non-dihydrate azithromycin oral suspensions |
| 06/29/2006 | CA2591706A1 Pharmaceutical formulations |
| 06/29/2006 | CA2591344A1 Controlled release of biological entities |
| 06/29/2006 | CA2591129A1 Treatment of inflammatory diseases |
| 06/29/2006 | CA2591076A1 Transdermal plaster with progesterone a-specific ligands (prasl) as an active ingredient |
| 06/29/2006 | CA2590802A1 Pharmaceutical compositions for sleep disorders |
| 06/29/2006 | CA2588692A1 Device for ophthalmic drug delivery |
| 06/29/2006 | CA2588442A1 Lipid particles comprising bioactive agents, methods of preparing and uses thereof |
| 06/29/2006 | CA2587250A1 Solid pharmaceutical compositions |
| 06/29/2006 | CA2585116A1 Sustained release formulation comprising bisphosphonate |
| 06/29/2006 | CA2575793A1 Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom |
| 06/28/2006 | EP1674474A1 Cyclic maltosyl maltose, cyclic maltosyl maltose synthase, method of producing the same and use thereof |
| 06/28/2006 | EP1674454A1 SUBSTITUTED 2-AMINO- 1,2,4 TRIAZOLO 1,5-a PYRIMIDINE DERIVATIVE AND USE THEREOF |
| 06/28/2006 | EP1674099A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 06/28/2006 | EP1674095A1 Phototherapy compositions |
| 06/28/2006 | EP1674094A1 Composition containing retinoic acid nanoparticles coated with polyvalent metal inorganic salt |
| 06/28/2006 | EP1674093A1 Method of controlling particle size of retinoic acid nanoparticles coated with polyvalent metal inorganic salt and nanoparticles obtained by the controlling method |
| 06/28/2006 | EP1674091A1 Ophthalmic composition for treating lacrimal disorders |
| 06/28/2006 | EP1674088A1 Jelly preparation containing biguanide medicine |
| 06/28/2006 | EP1674086A2 Shape-retentive hydrogel particle aggregates and their uses |
| 06/28/2006 | EP1674085A1 Solid lipidic particles as pharmaceutically acceptable fillers or carriers for inhalation |
| 06/28/2006 | EP1674084A2 Extended release oral dosage composition |
| 06/28/2006 | EP1674083A1 Tablet quickly disintegrating in oral cavity |
| 06/28/2006 | EP1674082A1 Process for the manufacture of sterile suspensions or lyophilisates of low-soluble basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament |
| 06/28/2006 | EP1674081A1 Preparation of lipid based nano-particles with a dual asymetric centrifuge |
| 06/28/2006 | EP1674080A1 Solid pharmaceutical composition comprising valsartan |
| 06/28/2006 | EP1674079A2 Pressurised metered dose inhalers (MDI) |
| 06/28/2006 | EP1674078A2 Fast dissolving orally consumable filsm containing an ion exchange resin as a taste masking agent |
| 06/28/2006 | EP1674077A1 Mucoadhesive pharmaceutical compositions comprising chemoattractants |
| 06/28/2006 | EP1674068A1 Dermal penetration enhancers and drug delivery systems involving same |
| 06/28/2006 | EP1673449A2 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 06/28/2006 | EP1673448A2 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 06/28/2006 | EP1673447A1 Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein |
| 06/28/2006 | EP1673425A1 Aqueous compositions comprising vesicles having certain vesicle permeability |
| 06/28/2006 | EP1673397A2 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies |
| 06/28/2006 | EP1673133A1 Fluid medication delivery device |
| 06/28/2006 | EP1673074A2 Liquid preparation containing tobramycin |
| 06/28/2006 | EP1673073A1 Sustained-release formulations |
| 06/28/2006 | EP1673072A2 A controlled release pharmaceutical composition and a process for preparing the same |
| 06/28/2006 | EP1673071A1 Improved stability of progestogen formulations |
| 06/28/2006 | EP1673070A1 Preparation method for sustained release microspheres using a dual-feed nozzle |
| 06/28/2006 | EP1673069A1 Method of administering cationic liposomes comprising an active drug |
| 06/28/2006 | EP1673068A1 Cosmetic composition promoting oxygen transport into the skin |
| 06/28/2006 | EP1673067A1 Monodispersed solid lipid particle compositions |
| 06/28/2006 | EP1673066A2 Aqueous aerosol preparation |
| 06/28/2006 | EP1673065A1 Microemulsions of retinoids, and pharmaceutical compositions containing them |
| 06/28/2006 | EP1673064A1 Pharmaceutical composition comprising anticonvulsant with taste mask coating |
| 06/28/2006 | EP1673063A1 Transdermal pharmaceutical composition |
| 06/28/2006 | EP1673062A2 Antimicrobial compositions and methods |
| 06/28/2006 | EP1594488B1 Stabilized pharmaceutical compositions of safingol and methods of using the same |
| 06/28/2006 | EP1526836B1 Implantable mems medicine delivery system |
| 06/28/2006 | EP1409034B1 Topical pharmaceutical formulation |
| 06/28/2006 | EP1372694B1 Liposome targeting of matrix metalloproteinase inhibitors |
| 06/28/2006 | EP1372547A4 Prosthetic foot with tunable performance |
| 06/28/2006 | EP1303387B1 Method of producing structures using centrifugal forces |
| 06/28/2006 | EP1299088B1 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient |
| 06/28/2006 | EP1259243B1 Bupropion metabolites and methods of their synthesis and use |
| 06/28/2006 | EP1255561B1 Proteosome influenza vaccine |
| 06/28/2006 | EP1208140B1 Rapidly decomposing chitosan-based pellets |
| 06/28/2006 | EP1173517A4 In situ forming hydrogels |
| 06/28/2006 | EP1156789B9 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 06/28/2006 | EP1107762B9 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 06/28/2006 | EP1100834B1 Polyanionic polymers which enhance fusogenicity |
| 06/28/2006 | EP1073439B1 Pharmaceutical composition |
| 06/28/2006 | EP1025859B1 Powdery pernasal compositions |
| 06/28/2006 | EP1017364A4 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 06/28/2006 | EP1011638A4 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 06/28/2006 | CN2790500Y Chinese medicine pasting bag |
| 06/28/2006 | CN1795014A Method for the preparation of molecular complexes |
| 06/28/2006 | CN1795013A Compositions for treating infection in cattle and swine |
| 06/28/2006 | CN1794998A Foamable pharmaceutical compositions and methods for treating a disorder |
| 06/28/2006 | CN1794993A Medicinal composition containing benidipine hydrochloride |
| 06/28/2006 | CN1794983A Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 06/28/2006 | CN1794980A Temporary embolization using inverse thermosensitive polymers |
| 06/28/2006 | CN1794979A Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom. |
| 06/28/2006 | CN1794978A Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 06/28/2006 | CN1794977A Antimicrobial quaternary ammonium organosilane coatings |
| 06/28/2006 | CN1794976A Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals |
| 06/28/2006 | CN1794975A Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
| 06/28/2006 | CN1794974A 药物递送体系 Drug delivery system |
| 06/28/2006 | CN1794973A Preserved ophthalmic compositions |
| 06/28/2006 | CN1794915A Aqueous compositions for disinfection and/or sterilization |
| 06/28/2006 | CN1793132A Derivative of cyclo membranousol kind and application thereof |
| 06/28/2006 | CN1793104A Process for extracting high purity alpha-linolenic acid from pepper category and medicine application thereof |
| 06/28/2006 | CN1792395A Method for keeping external use medicine placed at perineum |
| 06/28/2006 | CN1792387A Method for preparing digestive tract stent carried with medicines of micro-/nanometer balls |
| 06/28/2006 | CN1792372A Traditional Chinese medicine prepn. for treating diabetes |
| 06/28/2006 | CN1792366A Ginkgo leaves dispersion tablets, and its preparing method |
| 06/28/2006 | CN1792362A Abiduoer and its salts prepns. for vena administration, and its preparing method |
| 06/28/2006 | CN1261439C Cefixime sodium pharmaceutical composition and its preparation and application |
| 06/28/2006 | CN1261165C Preparation for prophylaxis of restenosis |
| 06/28/2006 | CN1261164C Medicine for burn and scald and its preparation |
| 06/28/2006 | CN1261161C Compound interferon inducing agent lozenge |
| 06/28/2006 | CN1261159C Freeze dried powder injection of hirudin and its preparation method |
| 06/28/2006 | CN1261154C Chinese medicine capsule for treating infection of urinary system and its preparing method |